Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Czech Republic

Zentiva To Develop Generic Viagra

May 2008 | Company News Alert

Czech pharmaceutical company Zentiva is developing a generic form of Eli Lilly's erectile dysfunction (ED) drug Viagra (sildenafil) to be sold in its existing markets. Zentiva, the fourth largest drugmaker from Central and Eastern Europe (CEE), has a dominant position in the Czech and Slovak markets, as well as achieving sales of over CZK1bn (US$61.3mn) in Turkey, Romania and Russia. The company's core business is developing generic drugs, so the successful production and marketing of sildenafil would represent a major

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries